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The loading of newly synthesised MHC class I molecules (MHCI) with peptides requires the involvement of several
endoplasmic reticulum (ER)-resident cofactors including calnexin, calreticulin, transporter associated with antigen processing,
ERp57 and tapasin. In the absence of tapasin, MHC I complexes are loaded with suboptimal peptides and their recognition by
cytotoxic T cells raised to high-affinity, immunodominant peptide epitopes is impaired. Here, we describe the cloning and
functional assessment of an alternative spliced form of tapasin. From the EST database, we obtained a partially spliced tapasin
cDNA that retained introns 4–6. When transfected into the tapasin-deficient cell line 0.220, the cDNA produced an alternatively
spliced tapasin transcript that contained intron 5 (74 bp). This introduced a new stop codon that terminated translation
immediately before the putative transmembrane domain and led to a tapasin molecule containing the lumenal domain plus 8
extra novel amino acids at its C-terminus. This molecule promoted peptide loading of HLA-B5 in 0.220 cell line, and restored
normal HLA-B5 surface expression. However, the peptides loaded onto HLA-B5 were suboptimal compared to those loaded
onto HLA-B5 in the presence of wild-type tapasin.
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Introduction
MHC class I complexes comprise a polymorphic,
glycosylated, transmembrane heavy chain (HC), a non-
covalently associated beta-2-microglobulin (b2-m) sub-
unit and a short peptide, usually of 8–10 amino acids.1
These complexes are expressed on the surface of
virtually all nucleated cells and provide a means of
discriminating self from nonself through recognition by
cytotoxic T cells (CTLs) and natural killer (NK) cells.
Most peptides that bind to MHC class I molecules are
derived from a fraction of newly but aberrantly syn-
thesised proteins that are targeted for cytosolic degrada-
tion.2,3 The peptides generated are transported by the
peptide transporter associated with antigen processing
(TAP) into the endoplasmic reticulum (ER), where they
are loaded onto peptide-receptive MHC class I com-
plexes. The peptide-loaded MHC class I complex is then
located to the cell surface for subsequent recognition.
The assembly of MHC class I molecules with peptides
that are able to stabilise the interaction between HC and
b2-m is a critical event in antigen presentation and
involves at least six ER-resident cofactors: calnexin,
calreticulin, ERp57, TAP, tapasin and ERAAP.4–10 The
first five of these associate to form the peptide-loading
complex (PLC), which is believed to promote the
assembly of peptide-receptive complexes with peptide
within the ER. Unlike calreticulin, calnexin and ERp57,
which have general chaperone functions, tapasin has a
specialised role in MHC class I assembly.11 It mediates an
interaction between TAP and newly synthesised MHC
class I molecules through two functional sites; one binds
to and stabilises the TAP heterodimer and the other
associates to the peptide-receptive MHC class I com-
plex.12 The TAP protein is more stable when associated
with tapasin, and peptide binding to TAP and transloca-
tion of peptides into the ER are increased when tapasin is
present. Tapasin also plays an active role in the
association of peptide-receptive MHC class I complexes
with the other ER cofactors and is absolutely required for
the association of MHC class I complexes with ERp57
and calreticulin within the PLC.13 It also enhances the
rate and extent of class I MHC loading with optimal
peptides.14–17 In tapasin-deficient cells, the repertoire of
class I-bound peptide is thus skewed towards less stably
binding ones, a phenomenon that is consistent with the
phenotype of C57BL/6 mice that lack tapasin and B2705
expressed in 0.220.18–20
Tapasin is a type I transmembrane glycoprotein with a
dilysine ER-retention motif (KxKxx) in its cytoplasmic
tail. The tapasin gene consists of eight exons within a
gene cluster approximately 190 kb centromeric to the
HLA-DPB2 locus. The leader sequence and the proline-
rich N-terminal portion of the lumenal domain are
encoded by the first four exons. Exon 5 encodes the
remainder of the lumenal domain, having homology
to the immunoglobulin superfamily. Exon 6 encodes a
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putative transmembrane domain and exons 7 and 8
encode a short cytoplasmic domain that contains the
ER-retention motif.21 The TAP-binding site has been
localised to exons 6–8.12 Accordingly, an engineered
construct of tapasin comprising its lumenal domains is
secreted and has been shown to restore the antigen-
presenting function of HLA-B8 in a tapasin-negative cell
line in the absence of HLA-B8 association with TAP.22
The N-terminal 50 amino acids of tapasin (encoded
within exon 2) are essential for its interaction with class I
MHC, CRT and Erp57, while a mutant mouse tapasin
lacking amino acids 334–342 (encoded within exon 5)
fails to bind to a mouse class I allele, but surprisingly,
facilitates its assembly and expression.23 We show here
that an alternatively spliced form of the tapasin gene that
encodes a truncated tapasin containing only the lumenal
domains of tapasin plus eight novel C-terminal residues
(KSWELCGI) is functional in terms of its ability to
promote optimal peptide loading, restore class I surface
expression and support a CTL response.
Results
An alternatively spliced tapasin gene (T5) encodes a
soluble form of tapasin
The published sequence of tapasin (GenBank, accession
AF009510) was used to search the GenBank database of
expressed tag sequences derived from a large panel of
cDNA libraries, using the TBLASTN local alignment
search tool.24 Several cDNAs were identified as having a
high degree of homology to tapasin and were acquired
from the UK HGMP resource centre (www.hgmp.mrc.
ac.uk) and sequenced. One of the clones revealed a
2202 bp sequence (Genbank, accession AF067286) that
was identical to the published cDNA sequence over the
first 1215 nucleotides, and thereafter was identical to the
genomic sequence, having retained introns 4–7 (T5,
Figure 1). A stop codon was identified within intron 4,
resulting in a transcript that was predicted to encode a
short version of tapasin including the proline-rich N-
terminal region of the molecule, but lacking the Ig SF
domain, transmembrane domain and cytoplasmic do-
main. To determine whether this truncated gene was
functional, it was transfected it into the tapasin-defective
B cell line 0.220-B5.
Surprisingly, RT-PCR analysis of the transfected cells
with a primer pair spanning exons 4 and 6 gave a 200 bp
product that was shorter than the expected product
derived from the transfected gene (B500 bp), but longer
than that expected for wild-type tapasin (Figure 2a). This
suggested that mRNA from the transfected cDNA was
processed in such a way as to excise intron 4 but retain
intron 5. We confirmed this using primers spanning
intron 5 (Figure 2b). A band of 194 bp was seen in 0.220-
B5T5 (lane 5) corresponding to 78 bp of intron 5 plus
116 bp of flanking sequence. The latter 116 bp product
was also seen in the nontransfected 0.220-B5 (lane 6), as
0.220 does possess genomic tapasin DNA but does not
express a functional tapasin protein due to a point
mutation in the splice-acceptor site of exon 2.25 These
data suggested that the constitutive mutant gene is
otherwise processed normally—an observation that is
consistent with the shortened tapasin seen in these cells.
Interestingly, a minor RT-PCR product with retained
intron 5 was also found in all control cell lines,
suggesting that the alternatively spliced form may be
generated in vivo from a naturally produced transcript.
We assume that the low level of detectable ‘wild-type’
tapasin products in LBL721.220-B5T5 in Figure 2b is due
to competition for transcription factors between the
endogenous gene and the highly expressed transgene.
Figure 2b also shows that both wild-type tapasin and a
transcript including intron 5 are expressed in peripheral
blood lymphocyte (PBL), the latter being the least
abundant. The level of each RT-PCR product did not
change after the activation of PBL with either 75 mg/ml
conA, 10mg ml PHA or 5mg/ml PWM (data not shown).
To confirm the nature of the major tapasin transcript
expressed in 0.220-B5T5, we cloned and sequenced the
RT-PCR product from B5T5 using primers flanking exons
4 and 6 (Figure 2a, lane 2). The sequencing results
showed that intron 4 was indeed spliced out, while
intron 5 was retained as part of the transcript (data not
shown, Figure 2c). As expected, 220-B5T5 cells expressed
a tapasin protein that was slightly smaller (45 kDa) than
wild-type tapasin (48 kDa) (Figure 3a). When T5 cDNA
was translated in vitro, where no further processing of T5
transcripts can occur, the expected product of around
35 kDa was generated corresponding to exons 1–4
(Figure 3a, lane 7). Western blot analysis of various cell
lines was carried out in an attempt to identify either of
these tapasin splice variants at the protein level. Figure 3b
shows that human monocyte-derived dendritic cell lines
of both immature and mature phenotype do not express
any altered tapasin protein. Similarly, when a panel of
tissue-specific protein blots were probed with the
antitapasin antisera only the full-length form was seen
in the spleen, lung and placenta, with little tapasin
protein identified in uterus, brain and kidney lysates.
Figure 3c shows the addition of the eight novel amino
acids (KSWELCGI) that are in-frame with the terminal
bases of the preceeding exon 5. The full-length tapasin
would include a further 44 amino acids encoded from
exons 6–8. Therefore, the 3 kDa difference between the
two tapasin forms relates to the 36 amino-acid truncation
of the full-length tapasin form. The truncated T5-derived
tapasin is likely to be secreted, since an analogous
soluble construct of tapasin comprising exons 1–5 with
eight amino acids from exon 6 is secreted when
transfected into 0.220 (data not shown).
Alternatively spliced tapasin restores class I surface
expression and rescues the presentation of HIV-gag
epitope in 0.220-B8 cell line to a B8-restricted CTL
Many MHC class I alleles are expressed at low levels at
the cell surface when transfected into the tapasin-
deficient cell LBL721.220 as a result of their inefficient
assembly with peptides.26,27 Figure 4a shows that the cell
surface expression of HLA-B5 is lower in 721.220
compared to that of class I in the tapasin-competent cell
line 221.A24. However, surface HLA-B5 expression is
restored by transfection of the T5 cDNA, to a level
approaching MHC class I expression seen in 221-A24. A
similar result was obtained for HLA-B8 (data not
shown). This indicates that the alternatively spliced gene
product is able to promote the loading of class I MHC
with peptides.
The apparent restoration of HLA-B5 surface expres-
sion by tapasin T5 led us to determine whether the
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antigen-presenting function of class I molecules is
restored by this protein. HLA-B8 is one of the class I
MHC alleles whose surface expression is reduced by the
absence of tapasin. As shown in Figure 4b, although
0.220-B8 is able to present exogenously added synthetic
peptide to B8-restricted CTL, it is unable to present the
HIV-1-gag epitope SLYNTVATL from an endogenous
source (ie after vaccinia infection). However, presenta-
tion of the endogenous epitope was restored in 0.220-B8
transfected with T5.
Figure 1 Alternatively spliced tapasin (T5). Comparison of the structure of mRNAs T5 and native tapasin with the genomic structure of
tapasin. The genomic sequence of the tapasin gene, based on the sequence of cosmid F0811 (Genbank accession number Z971840), was
aligned with the sequences of native tapasin (AF009519) and alternatively spliced tapasin (AF067286). Stop codons in introns 4 and 5 are
marked in bold type.
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T5-encoded tapasin does not associate with TAP
In order to confirm that the truncated tapasin did not
associate with TAP due to the absence of a transmem-
brane and cytoplasmic domain, we looked for the
coimmunprecipitation of the 45 kDa tapasin with TAP1.
Figure 5a shows that full-length tapasin (48 kDa) is
readily co-precipitated by an anti-TAP1 antibody in
immunocompetent LBL 221.45 cells, while in the 220-
B5T5 transfectant no coassociating tapasin is seen. The
truncated protein could be detected in the cell lysate
prior to immunoprecipitation (see Figure 3a, lane 5). The
results indicate that alternatively spliced tapasin fails to
associate with TAP, which confirms previous reports
using deliberately engineered soluble tapasin constructs.
Consequently, very little b2-m (a surrogate marker for
class I MHC) was seen to coprecipitate with anti-TAP
consistent with the MHC class I bridging function of
tapasin (Figure 5b).
T5-encoded tapasin promotes peptide loading and
restores normal trafficking rate of B5 in 0.220 cells
To investigate the effects of T5-encoded tapasin on
the peptide loading and trafficking of HLA-B5, pulse
chase experiments were carried out. Pulse-radiolabelled
lysates were incubated overnight at 41C to permit
dissociation of suboptimally loaded complexes prior to
immunoprecipitation with the conformationally sensi-
tive antibody W6/32. The majority of HLA-B5 synthe-
sised in 0.220 were consistent with this phenotype
leading to an insufficient number of W6/32 molecules
for visualisation after immunoprecipitation (data not
shown). However, when transfected with T5, there is a
significant amount of HLA-B5 precipitated in the 0.220-
B5 cells (Figure 6a). The maturation rate of HLA-B5 is
approximately the same as in 0.45, which expresses full-
length tapasin (Figure 6a). Notably, the amount of endo-
H-resistant HLA-B5 immunoprecipitated from 0.220-T5
begins to decline after 2 h chase, whereas in 0.45, the
levels remain stable (Figure 6b). We have previously
shown that this phenomenon is indicative of suboptimal
peptide loading of MHC class I, and suggests that a
different repertoire of peptides may be loaded onto
HLA-B5 in the presence of the soluble tapasin variant.
To test this possibility, we measured the thermostabil-
ity of HLA-B5molecules assembled in 0.220-B5T5 com-
pared to those synthesised in 0.45. We have shown that
this assay is a good indicator of the average affinity of
peptides bound to a cohort of class I MHC.14,28,29 Lysates
were precleared for 1 h at 41C with monoclonal antibody
BB7.2 that was previously shown to remove all HLA-A2
molecules (present in 0.45 but not 0.220-B5T5, data not
shown). Figure 7 shows that similar amounts of HLA-B5
were recovered from both cells at 41C, but those
recovered from 0.220-B5T5 were less thermostable, with
loss of almost half the molecules at 261C and over 60%
loss at 371C. These results indicate that although the
soluble tapasin restored cell surface expression of HLA-
B5 and presentation of an immunodominant T-cell
epitope, it did not completely restore the loading of
optimal peptides capable of stabilising MHC class I at
physiological temperatures.
Discussion
The presence of an incompletely processed tapasin-
encoding mRNA in several EST databases generated from
libraries of diverse cellular and species origin suggested
that the T5 transcript with retained introns 5–7 repre-
sented an alternatively spliced product and not a
processing intermediate isolated from contaminating
nuclear RNA. This was confirmed by our ability to detect
transcripts that included intron 5 in highly purified
preparations of cytosolic mRNA from various sources.
However, upon transfection into the B-cell line 0.220-
B5, this transcript was processed further to remove
intron 5, yielding a transcript that encoded the lumenal
domain of tapasin. This is the first time that a soluble
tapasin protein has been shown to arise from an mRNA
containing all eight exons. Given these observations, it is
possible that T5 represents a naturally occurring inter-
mediate generated during the splicing of tapasin pre-
mRNA that is committed to the generation of a soluble
isoform of the tapasin protein, but that this is a minor
pathway given the low level of detection of ‘intron 5-in.’
transcripts in normal cells. Our inability to detect this
soluble isoform does not imply that it does not naturally
exist, as specific cellular signals may be necessary to
induce its generation. Such signals may be pathogen
derived or relate to specific cell processes, that is,
crosspresentation/tolerance. It is possible that the rate
Figure 2 Expression of truncated tapasin in 0.220-B5T5 transfec-
tants. (a) PCR using template cDNA from 220-B5 (lane 2) and 220-
B5T5 (lane 3) with a primer pair spanning introns 4 and 5. (b) PCR
using template cDNA prepared from PBL (lane 3), 220-B8 (lane 4),
0.220-B5T5 (lane 5), 221 (lane 7) and 221-A24 (lane 8) with a primer
pair spanning intron 5. The band at 194 bp corresponds to the
expected product from T5 transcript and the band at 116 bp from the
wild-type tapasin. Lane 2 is the negative control for RT and PCR
without added RNA. (c) Schematic diagram comparing the intron/
exon organisation of the T5 transcript (generated by in vitro
translation) and the processed T5 transcript (generated by transfec-
tion into B cells) with native, full-length tapasin (genomic, top;
mRNA, bottom). Stars indicate the position of the most 50
translation stop codons in T5 and processed T5.
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at which intron 5 is excised from pre-mRNA relative to
other introns (ie the sequence in which the introns are
spliced) determines the level of T5-like transcripts, as
has been shown for some metazoan genes.30 Although
we found that the levels of T5-like transcripts in
normal lymphocytes did not change upon activation,
other cellular changes may affect the alternative
splicing of this gene, as has been described for others,
including environmental stress, malignant transformation,
developmental processes and infection.31
We do not know whether the generation of a soluble
tapasin will have any physiological significance. The
expression of a soluble tapasin in normal cells may
modulate the repertoire of peptides that are presented at
the cell surface, which may in turn influence the
recognition of target cells by CTLs and NK cells. Such
codominant expression may be important for preventing
the presentation of certain CTL epitopes, while at the
same time maintaining good cell surface expression of
tapasin-dependent class I MHC molecules that are
ligands for NK-inhibitory receptors such as HLA-E.
Alternatively, the production of soluble tapasin, which
could access intracellular compartments distal to the ER,
may be important in assisting peptide loading of MHC
class I molecules at these alternative sites. This may have
implications for MHC class I crosspresentation within
Figure 3 Alternatively spliced tapasin encodes a shorter version of tapasin in 0.220-B5. (a) 0.221-A24 (lanes 1 and 2), or 220 (lanes 3 and 4) or
220-B5 (lanes 5 and 6) cells were lysed in 1% NP-40 and incubated with (þ ) or without () endoglycosidase H to remove immature N-linked
glycans, fractionated by SDS-PAGE and immunoblotted with an antiserum raised to the N-terminus of tapasin. In a separate experiment, T5
cDNA (lane 7) and native tapasin (lane 8) were translated in vitro (as described in Materials and methods section) and the product analysed
by Western blotting. (b) Western blot analysis of mature and immature human dendritic cells (top panel) and an array of human tissues
(bottom panel) with an antiserum to tapasin. Full-length tapasin expressed in 0.221, and a soluble construct of tapasin having the same
molecular size as the processed T5 product expressed in 0.220 are included in the top panel for comparison. (c) Comparison of the predicted
amino-acid sequence of the processed T5 transcript and native, full-length tapasin. The additional eight amino acids (KSWELCGI) are seen
after amino acid 384 of the mature protein (404 aa from methionine).
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Figure 4 T5 restores normal surface expression of HLA-B5
and rescues CTL recognition. (a) Cell surface expression of MHC
class I complexes on 0.221, 220-B5, 221-A24 and 0.220-B5-T5
determined by flow cytometry with W6/32. (b) Recognition of
0.220-B8 or 220-B8 transfected with T5 (0.220-B8T5), by HLA-B8-
restricted anti-HIV-gag CTL, after being infected with HIV-gag-vac
(triangle), mock treated (circle) or pulsed with 10 mM peptide
(square).
Figure 5 T5-encoded tapasin does not bind to TAP and results
in the loss of MHC class I molecules from the PLC. Immunopre-
cipitates from lysates of 0.220B5T5 and the related (tapasin-
competent) line 0.45 were prepared with anti-TAP2 antiserum
under conditions that preserve the integrity of the PLC. These were
fractionated by SDS-PAGE and immunoblotted with antisera to
either tapasin (a) or b2-m (b) to detect the presence of MHC class I
in the complex.
Figure 6 Intracellular maturation of HLA-B5 in T5-transfected
0.220-B5 cells 0.220-B5T5 and 0.45 cells were pulse labelled for
10 min and chased for different time periods as indicated. Lysates
were immunoprecipitated with mAb W6/32, digested with endo-H
and resolved on 12.5% SDS-PAGE (a), and the band intensity of
mature class I HCs (endo-H-resistant) 0.45 (filled circle) and 0.220-
B5T5 (open circle) was quantitated (b).
Figure 7 Expressed HLA-B5 in 220-B5T5 is less stable than that in
0.45, the HLA-B5-expressing wild-type counterpart of 0.220-B5
0.220-B5T5 and 0.45 cells were labelled for 40 min. After a short
preclearing step at 41C (see Materials and methods section), the
supernatants were incubated for 1 h at 41C, 261C or 371C as
indicated, before recovering assembled HLA-B5 with mAb W6/32.
The class I HCs were resolved by SDS-PAGE (top panel) and
quantified by autoradiography (bottom panel).
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compartments such as endosomes or the MIIC, where
MHC class I complexes have been previously identified
and investigated for peptide editing and exchange.32–34
Materials and methods
Cells and antibodies
All cells were cultured in RPMI 1640 supplemented with
10% FCS, glutamine and antibiotics 721.220 (0.220),
721.221 (0.221) and their respective HLA transfectants,
0.220-B5, 0.220-B8, 0.221-A24 and HLA-B5-expressing
hemizygous cell 721.45, were kind gifts from R DeMars
(University of Wisconsin). Human DC cell lines were
derived from CD14-positive monocytes as described
previously.35 PBLs were isolated from whole blood by
standard percol centrifugation and maintained in culture
overnight. The monoclonal antibody W6/32 was pur-
ified by standard protein A affinity chromatography. The
antibody recognises a conformation-sensitive, mono-
morphic epitope on HLA-A, -B and –C, and requires
that the HC be assembled with b2-m.36 The antitapasin
antibody (T66) was raised in rabbits against the first 62
amino acids of mature tapasin fused to GST protein
using pGEX vector (Pharmacia). The anti-TAP2 antiser-
um was a gift from J Neefjes (Netherlands Cancer
Institute). Rabbit anti-calreticulin antiserum was pur-
chased from Affinity Bioreagents Inc. BBM1.1 was
purified by standard protein A affinity chromatography
and recognises human b2-m.37
Alternatively spliced tapasin gene subcloning
cDNAs obtained from UK HGMP resource Centre
(Cambridge, UK) based on their sequence homology to
tapasin were sequenced both manually and automati-
cally using an ABI sequencer. For transfections, the EST
clone corresponding to exons 1–8 containing introns 5–7
(T5) was subcloned into pcDNA 3.0. Clones were
sequenced to ensure correct orientation.
Transfection
A total of 1107 0.220-B5 cells were washed twice with
15 ml of phosphate-buffered saline (PBS), resuspended in
0.9 ml of PBS and then mixed with 100 ml of pcDNA3
containing the T5 fragment in 0.4 cm electrode gap
curvettes (Bio-Rad) and kept on ice for 20 min. The
electroporation was performed using the Gene Pulser
(BioRad) set at 210 V and 960mF. Stable transfectants were
selected with 500 mg/ml G418 (Life Technology) and
screened for MHC class I expression by FACS. The
positive cell lines were subcloned by limited dilution and
clones were selected for further analysis based on their
cell surface expression of MHC class I.
Pulse chase and immunoprecipitation
A total of 1107 cells were starved in 4 ml of cysteine-
and methionine-deficient RPMI 1640 (Sigma) with 10%
dialysed FCS at 371C for 30 min. The cells were spun
down and resuspended in 0.5 ml of the same solution
containing 200mCi Promix (Amersham) and incubated at
371C for a further 10 min. The labelled cells were washed
with 20 ml of cold PBS and immediately lysed in 1 ml of
TBS containing 1% digitonin, protease inhibitor cocktail
(Sigma), and then kept on ice for 30 min. After removing
nuclei by centrifugation at 13.00 r.p.m. for 30 min, the cell
lysates were precleared by incubation at 41C either
overnight (or for 20 min in the case of thermostability
assays) with 1% normal rabbit serum (Sigma) and 50 ml of
prewashed (0.1% digitonin) Staph A (Sigma). For
immunoprecipitation of HLA-B5 with mAb W6/32,
preclearing with mAb BB7.2 was performed. Antibodies
were added to precleared supernatants for 90 min before
adding 50 ml of Protein A–Sepharose 4B (Sigma) and
rotated at 41C for further 30 min. Immunoprecipitates
were resolved in 12.5% SDS-PAGE. Immunoglobulin
bands were visualised with Coomassie blue to confirm
equivalent loading of each lane. Gels were then soaked in
amplify (Pharmacia) for 15 min, dried and exposed to an
X-ray film overnight. Alternatively, gels were processed
for immunoblotting (see below).
In vitro translation
Transcription and translation were carried out simulta-
neously using TNT Quick coupled Transcription/trans-
lation systems (Promega) according to the
manufacturer’s instructions. Briefly, 1mg of plasmid
was mixed with 40 ml of master mix and 20mCi of Promix
(Amersham) and nuclease-free water was added to a
final volume of 50ml. The reaction was carried out at
301C for 90 min.
Immunoblotting
Proteins were transferred from polyacrylamide gels to
Hybond membrane (Amersham) electrophoretically over
90 min at 25 V. After blocking membranes with 2.5%
skimmed milk in PBS, the membrane was incubated with
anti-tapasin antiserum (1:10 000 dilution) in 2.5%
skimmed milk/0.2% Tween-20 PBS for at least 1 h at
room temperature. The membrane was washed with
PBS/Tween-20 twice and incubated with anti-rabbit
antibody conjugated to horseradish peroxidase. The
membrane was thoroughly washed with PBST and
visualised with an enhanced chemiluminescence detec-
tion system according to the manufacturer’s instructions
(Amersham). A multi-human tissue protein array (Bio-
Chain Institute, Hayward, CA, USA) was probed with
tapasin antiserum (1:5000 dilution) and anti-rabbit anti-
body conjugated to horseradish peroxidase (as above).
RT-PCR
mRNA was extracted from 1106 cells using an
mRNA Direct kit (Dynal). cDNA was synthesised using
standard random priming methods with MuMLV reverse
transcriptase (Promega) and RNAse inhibitor (Promega).
RT-PCR was carried out with the primers ATGGGG
CACGCTATGCCTGT as the forward primer and CT
ACGCTGTCCTCAAGGGAG as the reverse primer.
Amplification was carried out as follows: 4 min at 941C,
followed by 30 cycles of: 941C for 30 s, 451C for 30 s, 721C
for 1 min and final extension for 8 min at 721C.
FACS analysis
In all, 2 105 cells were incubated with a final concen-
tration of 10 mg/ml W6/32 in RPMI 1640 with 10% FCS
(10 mg/ml) at 41C for one hand washed with 10 ml cold
PBS twice. The cells were stained for 45 min at 41C in
0.5 ml PBS containing a 200-fold dilution of goat anti-
mouse Ig-FITC conjugate (Sigma). The cells were washed
with 0.5 ml of cold PBS three times and suspended in
0.3 ml of PBS containing 0.7% formaldehyde. The
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samples were analysed in a Becton-Dickinson Flow
Cytometer with minimum 20 000 cells counted.
CTL assays
Target cells were labelled with 51Cr for 90 min after being
infected with recombinant vaccinia virus at a multiplicity
of five overnight at 371C. After washing, the cells were
exposed to CTL in a standard 4-h Chromium release
assay. For peptide-sensitised targets, 10mM peptide was
included in CTL assay.
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